Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1745 (LINC01745) is a member of the long non-coding RNA (lncRNA) family, specifically a "long intergenic non-coding RNA." These RNAs are transcribed from genomic regions that do not overlap protein-coding genes and are typically longer than 200 nucleotides[5][1][6]. LINC01745 is not known to encode a protein. While the specific functional significance of LINC01745 has not been characterized in the literature, lincRNAs in general are recognized for their diverse roles in regulating transcription, remodeling chromatin, and influencing nuclear architecture and gene expression[6][7]. Although lncRNAs as a class are increasingly recognized as potential regulators, disease modifiers, and in some cases biomarkers, no evidence currently links LINC01745 specifically to a disease or therapeutic intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1745 (LINC01745).